Amneal Pharmaceuticals Inc (AMRX)
8.52 -0.04 (-0.47%) 01/22/25 [NASDAQ]
6.50 x 100 8.80 x 100
Realtime by (Cboe BZX)
6.50 x 100 8.80 x 100
Realtime - - (-) -
for Wed, Jan 22nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 702,468 | 701,780 | 659,191 | 616,981 | 620,040 |
Cost of Goods | 432,910 | 451,833 | 421,131 | 427,154 | 387,509 |
Gross Profit | 269,558 | 249,947 | 238,060 | 189,827 | 232,531 |
Operating Expenses | 181,659 | 155,310 | 248,937 | 175,788 | 157,392 |
Operating Income | 88,809 | 95,470 | -10,746 | 14,193 | 75,648 |
Interest Expense | 65,511 | 65,719 | 65,703 | 59,548 | 50,909 |
Other Income | -7,875 | -9,346 | 927 | -38,106 | -1,782 |
Pre-tax Income | 15,423 | 20,405 | -75,522 | -83,461 | 22,957 |
Income Tax | 3,666 | 3,618 | 6,156 | 9,883 | -2,076 |
Net Income Continuous | 11,757 | 16,787 | -81,678 | -93,344 | 25,033 |
Minority Interests | 11,913 | 10,793 | 9,965 | 5,305 | 15,351 |
Net Income | $-156 | $5,994 | $-91,643 | $-98,649 | $9,682 |
EPS Basic Total Ops | 0.00 | 0.02 | -0.30 | -0.57 | 0.06 |
EPS Basic Continuous Ops | 0.04 | 0.05 | -0.27 | -0.57 | 0.16 |
EPS Diluted Total Ops | 0.00 | 0.02 | -0.30 | -0.57 | 0.06 |
EPS Diluted Continuous Ops | 0.04 | 0.05 | -0.27 | -0.56 | 0.16 |
EPS Diluted Before Non-Recurring Items | 0.15 | 0.15 | 0.12 | 0.12 | 0.17 |
EBITDA(a) | $149,211 | $151,975 | $45,070 | $72,424 | $135,215 |